Skip to content

Abnormal Circulating B Type Natriuretic Peptide Concentration C4476997

Published: July 22, 2026Updated: August 25, 2026

B-type natriuretic peptide (BNP) is released by the heart when stressed. Elevated levels typically indicate heart problems such as heart failure. Management focuses on treating the underlying cardiac condition.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest Discomfort

Pressure, tightness, or pain in the chest that may radiate to the arm, jaw, or back.

Chest discomfort is a medical emergency. Call emergency services immediately.

!

Syncope

Fainting or loss of consciousness, often related to inadequate blood flow to the brain.

Fainting requires immediate medical evaluation. Call emergency services.

Peripheral Edema

(cardiovascular)

Swelling in the legs, ankles, or feet due to fluid retention from impaired heart function.

Frequency: 70-80% of patients

Fatigue

(constitutional)

Persistent tiredness and lack of energy that interferes with daily activities.

Frequency: 75-85% of patients

Shortness of Breath

(respiratory)

Difficulty breathing or feeling breathless, especially during physical activity or when lying flat.

Frequency: 80-90% of patients

Orthopnea

(respiratory)

Shortness of breath that occurs when lying flat, often requiring pillows to sleep.

Frequency: 50-60% of patients

Heart Palpitations

(cardiovascular)

Awareness of rapid, fluttering, or irregular heartbeat.

Frequency: 40-50% of patients

Persistent Cough

(respiratory)

Chronic cough, often dry or producing frothy sputum, due to fluid in the lungs.

Frequency: 45-55% of patients

Reduced Exercise Tolerance

(constitutional)

Inability to perform usual physical activities without unusual breathlessness or fatigue.

Frequency: 60-70% of patients

Paroxysmal Nocturnal Dyspnea

(respiratory)

Sudden shortness of breath that awakens you from sleep, often requiring sitting up to breathe.

Frequency: 20-30% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cardiac biomarker monitoring

Serial BNP measurements and cardiac function assessment to track changes and guide clinical management. Monitoring frequency depends on underlying etiology and severity of abnormal values.

monitoring
2

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Sodium and fluid management

Implementation of dietary sodium restriction and appropriate fluid intake regulation to reduce cardiac workload. This helps manage fluid balance and reduce strain on the cardiovascular system.

lifestyle

Additional treatment options

Cardiac-healthy nutrition plan

Adoption of DASH or similar heart-healthy dietary patterns emphasizing fruits, vegetables, whole grains, and lean proteins. These dietary modifications support overall cardiovascular health and may help normalize biomarker levels.

dietary

Cardiovascular medication review

Comprehensive review and optimization of cardiovascular medications that may affect cardiac function and BNP levels. Medication adjustments should be made under physician supervision with gradual changes.

medication

Cardiac imaging follow-up

Echocardiography or other cardiac imaging studies to evaluate cardiac structure and function when BNP abnormalities persist. Imaging helps identify underlying structural heart disease requiring specific intervention.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating B Type Natriuretic Peptide Concentration C4476997?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology. 2022;79(17):e263-e421.

guideline2022View source →
2

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal. 2021;42(36):3599-3726.

guideline2021View source →
3

Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. Circulation. 2017;136(6):e137-e161.

position_statement2017View source →
4

Natriuretic Peptides Studies Collaboration. Natriuretic Peptides and their receptors in the human heart: their diagnostic and therapeutic potential in heart failure. Heart Failure Reviews. 2019;24(4):537-549.

review2019
5

Roberts E, Ludman AJ, Dworzynski K, et al. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and meta-analysis. BMJ Open. 2015;5(4):e007438.

meta_analysis2015View source →
6

Lainchbury JG, Troughton RW, Strangman KM, et al. N-terminal pro-B-type natriuretic peptide-guided therapy in chronic heart failure. Circulation. 2010;122(3):270-279.

clinical_trial2010View source →
7

Braunwald E. Biomarkers in heart failure. New England Journal of Medicine. 2020;382(19):1818-1827.

review2020View source →
8

Mann DL, Zipes DP, Libby P, Bonow RO, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Elsevier; 2019: Chapter 25 - Natriuretic Peptides in Heart Failure.

textbook2019

Medication Comparisons

Compare medications used to treat Abnormal Circulating B Type Natriuretic Peptide Concentration C4476997. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy